Cargando…
Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke
Background and Purpose: Dual antiplatelet therapy (DAPT), compared to single antiplatelet therapy (SAPT), lowers the risk of stroke or death early after TIA and minor ischemic stroke. Prior trials excluded moderate to severe strokes, due to a potential increased risk of bleeding. We aimed to compare...
Autores principales: | Khazaal, Ossama, Rothstein, Aaron, Husain, Muhammad R., Broderick, Matthew, Cristancho, Daniel, Reyes-Esteves, Sahily, Khan, Farhan, Favilla, Christopher G., Messé, Steven R., Mullen, Michael T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488084/ https://www.ncbi.nlm.nih.gov/pubmed/34616353 http://dx.doi.org/10.3389/fneur.2021.728111 |
Ejemplares similares
-
Association Between Anxiety, Depression, and Post-traumatic Stress Disorder and Outcomes After Ischemic Stroke
por: Stein, Laura A., et al.
Publicado: (2018) -
Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021) -
Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
por: Alhazzani, Adel, et al.
Publicado: (2021) -
Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
por: Vališ, Martin, et al.
Publicado: (2021) -
Reliability of Past Medical History in a Single Hospital Participating in Get With The Guidelines‐Stroke Registry
por: Favilla, Christopher G., et al.
Publicado: (2022)